MXPA03002911A - Compuestos quimicos. - Google Patents

Compuestos quimicos.

Info

Publication number: MXPA03002911A
Authority: MX; Mexico
Prior art keywords: chemical compounds; compounds; solvates; salts; disclosed
Prior art date: 2000-10-03

Application number

MXPA03002911A

Other languages

English (en)

Inventor

Jason Scott Sawyer

Original Assignee

Lilly Icos Llc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-10-03

Filing date

2001-09-17

Publication date

2003-09-10

2001-09-17 Application filed by Lilly Icos Llc filed Critical Lilly Icos Llc

2003-09-10 Publication of MXPA03002911A publication Critical patent/MXPA03002911A/es

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
- C07D513/14—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D515/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D515/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
- C07D515/14—Ortho-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Cardiology (AREA)
Pulmonology (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Ophthalmology & Optometry (AREA)
Reproductive Health (AREA)
Endocrinology (AREA)
Gynecology & Obstetrics (AREA)
Orthopedic Medicine & Surgery (AREA)
Vascular Medicine (AREA)
Immunology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Hematology (AREA)
Biomedical Technology (AREA)
Diabetes (AREA)
Hospice & Palliative Care (AREA)
Pregnancy & Childbirth (AREA)
Otolaryngology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

MXPA03002911A 2000-10-03 2001-09-17 Compuestos quimicos. MXPA03002911A (es)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US23773400P	2000-10-03	2000-10-03
PCT/US2001/042175 WO2002028865A2 (en)	2000-10-03	2001-09-17	Condensed pyridoindole derivatives

Publications (1)

Publication Number	Publication Date
MXPA03002911A true MXPA03002911A (es)	2003-09-10

Family

ID=22894936

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MXPA03002911A MXPA03002911A (es)	2000-10-03	2001-09-17	Compuestos quimicos.

Country Status (10)

Country	Link
US (1)	US6858620B2 (es)
EP (1)	EP1335923B1 (es)
JP (1)	JP4246488B2 (es)
AT (1)	ATE332903T1 (es)
AU (1)	AU2002213421A1 (es)
CA (1)	CA2423312A1 (es)
DE (1)	DE60121461T2 (es)
ES (1)	ES2267831T3 (es)
MX (1)	MXPA03002911A (es)
WO (1)	WO2002028865A2 (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7115621B2 (en)	2001-04-25	2006-10-03	Lilly Icos Llc	Chemical compounds
PT1572173E (pt)	2002-12-13	2010-05-10	Warner Lambert Co	Ligando alfa-2-delta para tratar sintomas do tracto urinário inferior
WO2005079808A1 (en)	2004-01-22	2005-09-01	Pfizer Limited	Triazole derivatives which inhibit vasopressin antagonistic activity
WO2005089752A2 (en) *	2004-03-15	2005-09-29	Ptc Therapeutics, Inc.	Tetra-cyclic carboline derivatives for inhibiting angiogenesis
CN101106997A (zh)	2004-08-17	2008-01-16	约翰·霍普金斯大学	Pde5抑制剂组合物及治疗心脏病征候的方法
CA2576619A1 (en)	2004-08-18	2006-02-23	Altana Pharma Ag	Benzothienopyridines for use as inhibitors of eg5 kinesin
AU2006208709A1 (en) *	2005-01-27	2006-08-03	4Sc Ag	Novel indolopyridines , benzofuranopyridines and benzothienopyridines
WO2006079644A1 (en) *	2005-01-28	2006-08-03	Nycomed Gmbh	Indolopyridines, benzofuranopyridines and benzothienopyridines
US8530493B2 (en)	2006-02-22	2013-09-10	4Sc Ag	Indolopyridines as Eg5 kinesin modulators
FR2914924A1 (fr) *	2007-04-13	2008-10-17	Fourtillan Snc	Derives de 4,5,11,11a-tetrahydro-1h,6h-oxazolo[3',4': 1,6] pyrido[3,4-b]indol-3-one et leur utilisation en therapeutique.
EP2476680B1 (en)	2008-01-11	2014-08-27	Albany Molecular Research, Inc.	(1-Azinone)-Substituted Pyridoindoles
US20120283282A1 (en) *	2009-06-18	2012-11-08	Arleen Rifkind	Photoproducts of Tryptophan, Their Synthesis and Uses Thereof
WO2011003007A1 (en)	2009-07-01	2011-01-06	Albany Molecular Research, Inc.	Azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine mch-1 antagonists, methods of making, and use thereof
US8618299B2 (en)	2009-07-01	2013-12-31	Albany Molecular Research, Inc.	Azinone-substituted azapolycycle MCH-1 antagonists, methods of making, and use thereof
WO2011003021A1 (en)	2009-07-01	2011-01-06	Albany Molecular Research, Inc.	Azinone-substituted azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine mch-1 antagonists, methods of making, and use thereof
JP2012532144A (ja)	2009-07-01	2012-12-13	アルバニーモレキュラーリサーチ，インコーポレイテッド	アジノン置換アゼピノ［ｂ］インドールおよびピリド−ピロロ−アゼピンｍｃｈ−１拮抗薬、ならびにその作製方法および使用
WO2012088038A2 (en)	2010-12-21	2012-06-28	Albany Molecular Research, Inc.	Piperazinone-substituted tetrahydro-carboline mch-1 antagonists, methods of making, and uses thereof
WO2012088124A2 (en)	2010-12-21	2012-06-28	Albany Molecular Research, Inc.	Tetrahydro-azacarboline mch-1 antagonists, methods of making, and uses thereof
ES2882258T3 (es)	2012-12-21	2021-12-01	Mayo Found Medical Education & Res	Métodos y materiales para tratar estenosis de la válvula aórtica calcificada
JP2016537388A (ja)	2013-11-22	2016-12-01	ファーマケア，インク．	四環系のオートタキシン阻害剤
HUE055213T2 (hu)	2013-11-22	2021-11-29	Sabre Therapeutics Llc	Autotaxin inhibitor vegyületek
SG11201605519QA (en) *	2014-01-23	2016-08-30	Asahi Chemical Ind	Adhesive composition and pressure-sensitive adhesive tape
CA2986759C (en)	2015-05-27	2025-06-17	Sabre Therapeutics Llc	AUTOTAXIN INHIBITORS AND THEIR USES
WO2020210707A1 (en)	2019-04-10	2020-10-15	Mayo Foundation For Medical Education And Research	Methods and materials for gender-dependent treatment of cardiovascular dysfunction
FI130627B (en)	2021-03-31	2023-12-18	Equinorm Ltd	Novel heterocyclic compounds and their use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8420969D0 (en) *	1984-08-17	1984-09-19	Tanabe Seiyaku Co	Tetrahydro-beta-carboline derivative
EP0357122A3 (en) *	1988-08-29	1991-10-23	Duphar International Research B.V	Use of beta-carbolines, their bio-isosteric benzofuran and benzothiophene analogues for the manufacture of a medicament having cytostatic properties
US5622960A (en) *	1992-04-14	1997-04-22	The United States Of America As Represented By The Department Of Health And Human Services	Topoisomerase II inhibitors and therapeutic uses therefor
GB9514473D0 (en) *	1995-07-14	1995-09-13	Glaxo Lab Sa	Chemical compounds

2001
- 2001-09-17 EP EP01981804A patent/EP1335923B1/en not_active Expired - Lifetime
- 2001-09-17 AU AU2002213421A patent/AU2002213421A1/en not_active Abandoned
- 2001-09-17 US US10/363,528 patent/US6858620B2/en not_active Expired - Fee Related
- 2001-09-17 MX MXPA03002911A patent/MXPA03002911A/es active IP Right Grant
- 2001-09-17 CA CA002423312A patent/CA2423312A1/en not_active Abandoned
- 2001-09-17 JP JP2002532448A patent/JP4246488B2/ja not_active Expired - Fee Related
- 2001-09-17 WO PCT/US2001/042175 patent/WO2002028865A2/en not_active Ceased
- 2001-09-17 ES ES01981804T patent/ES2267831T3/es not_active Expired - Lifetime
- 2001-09-17 DE DE60121461T patent/DE60121461T2/de not_active Expired - Lifetime
- 2001-09-17 AT AT01981804T patent/ATE332903T1/de not_active IP Right Cessation

Also Published As

Publication number	Publication date
JP4246488B2 (ja)	2009-04-02
ATE332903T1 (de)	2006-08-15
US6858620B2 (en)	2005-02-22
JP2004511448A (ja)	2004-04-15
CA2423312A1 (en)	2002-04-11
ES2267831T3 (es)	2007-03-16
EP1335923B1 (en)	2006-07-12
WO2002028865A3 (en)	2003-02-27
US20040082787A1 (en)	2004-04-29
DE60121461D1 (de)	2006-08-24
AU2002213421A1 (en)	2002-04-15
WO2002028865A2 (en)	2002-04-11
EP1335923A2 (en)	2003-08-20
DE60121461T2 (de)	2007-02-08

Publication	Publication Date	Title
DE60112974D1 (en)	2005-09-29	Carbolinderivate
MXPA03002911A (es)	2003-09-10	Compuestos quimicos.
MXPA02012076A (es)	2003-06-06	Compuestos quimicos.
MXPA02012659A (es)	2003-09-22	Derivados de pirazindiona condensados.
MXPA03007142A (es)	2004-05-24	Derivados de carbolina.
GB9514473D0 (en)	1995-09-13	Chemical compounds
BG108269A (en)	2004-12-30	Pyrazolopyrimidines as therapeutic agents
GB0124933D0 (en)	2001-12-05	Chemical compounds
BG108268A (en)	2005-04-30	Pyrazolopyrimidines as therapeutic agents
MXPA03009750A (es)	2004-06-30	Compuestos quimicos.
WO2002070469A3 (en)	2004-03-04	Selective pde3b inhibitors and use of the same in therapy
MXPA02012470A (es)	2004-01-26	Inhibidores de fosfodiesterasa especificos para gmp ciclico.
MXPA03002909A (es)	2003-09-10	Compuestos quimicos.
MXPA02012472A (es)	2004-01-26	Compuestos quimicos.
MXPA03003971A (es)	2004-02-12	Derivados de indol como inhibidores de pde5.
MXPA03004023A (es)	2004-02-12	Compuestos quimicos.
CA2445620A1 (en)	2002-12-12	Tetracyclic compounds as pde5-inhibitors
MXPA03000887A (es)	2004-04-05	Derivados heterociclicos fusionados como inhibidores de fosfodiesterasa.

Legal Events

Date	Code	Title	Description
2005-12-14	FG	Grant or registration